Ureteral obstruction in rabbits is characterized by mononuclear cell invasion of the renal cortex and proliferative fibrosis that is associated with exaggerated prostaglandin synthesis in response to vasoactive and inflammatory cell agonists. In this investigation, we studied the effects of the chemotactic peptide Af-formylmethionyl-leucyl-phenylalanine (fMLP) and bradykinin (BK) on eicosanoid synthesis and renal vascular resistance in the ex vivo perfused hydronephrotic kidney (HNK). Administration of fMLP resulted in the dose-dependent synthesis of leukotrienes, thromboxane A, (TXAj), prostaglandin E 2 (PGEj), and prostacyclin (PGLJ. Peptidoleukotriene synthesis was monitored by specific radioimmunoassay and by guinea pig ileum bioassay and it was then validated by inhibition of the ileal contractile activity with the peptidoleukotriene receptor antagonist FPL-55712. The leukotrienes produced were identified as LTB 4 , LTC 4 , LTD 4 , and LTE 4 by comigration with authentic standards on reverse phase high-performance liquid chromatography (RP-HPLC) and by ultraviolet spectroscopy. BK administration stimulated the synthesis of TXA 2 , PGE 2 , and PGI 2 but not the synthesis of leukotrienes, in contrast to the results with fMLP, suggesting the involvement of different cell types. Administration of fMLP to the HNK also resulted in a renal vasoconstriction that was partially inhibited by FPL-55712 and that was completely inhibited by the thromboxane synthase inhibitor OKY-1581. Consistent with this result, exogenous administration of LTC 4 resulted in the synthesis of TXA 2 and in a renal vasoconstriction that was inhibited by either FPL-55712 or OKY-1581. These studies provide conclusive evidence that leukotrienes are produced in renal inflammation, that endogenously produced LTC 4 can stimulate the synthesis of TXA 2 , and that LTC 4 -induced vasoconstriction is mediated by the production of TX A,. The vasoconstrictor effects of endogenously produced leukotrienes and thromboxane suggest a pathophysiologic role for these substances in renal inflammation. (Circulation Research 1987;61:514-522)
P revious studies of the ex vivo perfused rabbit hydronephrotic kidney (HNK) have demonstrated that administration of bradykinin (BK) and angiotensin II result in the synthesis of large amounts of prostaglandin E 2 (PGEj) and thromboxane A 2 (TXA 2 ).' The ability of agonists to stimulate prostaglandin production in these preparations increases with the time of ex vivo perfusion. Treatment of hydronephrotic animals with lipopolysaccharide/endotoxin (LPS) 1 hour before removal of the kidney eliminates this time dependence and results in maximal agonist-stimulated synthesis of eicosanoid metabolites at initiation of ex vivo perfusion. 2 The HNK's exaggerated prostaglandin synthetic response to agonists occurs in temporal association with macrophage infiltration and fibroblast proliferation in the renal cortex. 3 " 3 Unobstructed contralateral kidneys (CLKs) taken from rabbits made hydronephrotic are similar both histologically and biochemically to kidneys from rabbits without ureter obstruction. Both the normal kidney and CLK in comparison with the HNK are devoid of inflammatory cells, lack fibroplasia, 3 * 5 and exhibit low eicosanoid synthetic capacity in response to agonists. 6 The data from experiments using normal kidneys and CLKs were combined and reported as CLK values.
Several lines of experimental evidence indicate that the presence of inflammatory cells in the HNK is intimately related to the enhanced prostaglandin synthesis. In HNK models devoid of inflammatory cell infiltrates (i.e., the cat, 7 rabbits made leukopenic with nitrogen mustard treatment before ureter obstruction, 2 and postobstructed HNK rabbits 58 ), agonist stimulation does not enhance PGE^ and TXA 2 production. The activation of macrophages in vitro with LPS 9 and enhanced prostaglandin synthetic capacity of the HNK after LPS treatment 2 -810 suggest that inflammatory cells play a major role in the agonist-stimulated prostaglandin production in the HNK.
Macrophages produce not only prostaglandins but also contain 5-lipoxygenase and have been shown in vitro to synthesize leukotrienes.""' 5 While it remains unclear which cells are directly responsible for agoniststimulated eicosanoid synthesis in the rabbit HNK, the presence of inflammatory cells in the HNK led us to hypothesize that leukotrienes would be an important eicosanoid product of the rabbit HNK. The potential pathophysiologic importance of leukotriene synthesis in renal inflammation is suggested by leukotrienes' ability to cause vascular leakage, contraction of smooth A previous investigation in another model of inflammation, rabbit myocardial infarction, showed that fMLP stimulated the dose-dependent synthesis of peptidoleukotrienes and prostaglandins but that BK stimulated only the synthesis of prostaglandins.' 6 Based on this observation, we have tested the hypothesis that the HNK can produce leukotrienes. We now report that the rabbit HNK responds to fMLP with the synthesis of leukotrienes. These endogenously produced leukotrienes stimulate the synthesis of TXA 2 that, in turn, results in increased renal vascular resistance. 
Materials and Methods

Ureteral Obstruction and Ex Vivo Kidney Perfusion
Unilateral ureteral obstruction was carried out in male New Zealand white rabbits by a previously described procedure. 6 Briefly, animals were anesthetized with sodium pentobarbital (30 mg/kg), the bladder was extruded through a small abdominal incision, and a silk suture was tied around the left ureter. The incision was repaired, and the animals were allowed to recover for 3 days. One hour before sacrifice, some animals received LPS (8 mg/kg i.v.). At the time of sacrifice, the animals were heparinized (500 U/animal), reanesthetized with sodium pentobarbital, and their renal arteries were cannulated with polyethylene tubing. The unobstructed CLK and the HNK or kidneys from rabbits not made hydronephrotic were excised, placed in separate warming jackets, and perfused at a constant flow of 10 ml/min with oxygenated (95% O 2 -5% CO 2 ) Krebs-Henseleit buffer at 37° C. Renal perfusion pressure was monitored with a sidearm in the perfusion apparatus using a P-1000-A pressure transducer (Narco Bio-Systems, Inc., Houston, Tex.) and a Harvard 350 recorder (South Natick, Mass.). Basal perfusion pressure was comparable in both the HNK and CLK, consistent with the relatively low basal eicosanoid metabolite synthesis that occurs in the absence of agonist. The most apparent renal resistance changes between the HNK and CLK are noted during agonist (BK or fMLP) stimulation. The renal venous effluent was allowed to sequentially flow over 2 smooth muscle assay organs: rabbit thoracic aorta strips, to detect TXA2 -like activity, and guinea pig ileum strips, to detect peptidoleukotriene activity. The contraction of the smooth muscle strips was monitored by isotonic myographs and a chart recorder. The assay tissues were also superfused with a mixture of antagonists to render them insensitive to catecholamines, acetylcholine, serotonin, and histamine and superfused with indomethacin to prevent the assay tissue from synthesizing prostaglandins. 18 Before the experimental protocol, the kidneys were perfused ex vivo for 1 hour. At this time, the kidneys were challenged with intra-arterial bolus administration of either BK (30-1,000 ng) or fMLP (30-1,000 ng). Five-minute collections (50 ml) of renal venous effluent were made before and immediately following agonist administration. Aliquots (1 ml) of the effluent were saved (-20° C) for prostaglandin radioimmunoassay (RIA), and the remaining effluent was applied to a C-18 octadecylsilyl (ODS) column (as described below) for subsequent analysis for leukotrienes by RIA and reverse phase high-performance liquid chromatography (RP-HPLC). In inhibitor experiments, OKY-1581 (final concentration, 1 /xg/ml) or FPL-55712 (0.4 Aig/ml) was administered directly into the renal perfusion fluid.
Radioimmunoassay
Renal venous effluent was assayed for 6-keto-PGF la , the stable metabolite of prostacyclin (PGLJ), by a previously described method. 7 PGEj and TXB 2 , the stable metabolite of TXA 2 , levels were measured by RIA using '"I labelled ligand. Throughout the text and the discussion of the data, references to detectable PGI 2 or TXA 2 , are based on the 6-keto-PGF, a and TXB 2 immunoassays, respectively. The ['"IJPGEj and TXB 2 were prepared by the method of Maclouf et al." The [ 123 I]PGE, assay has previously been described. 20 The [ m I]TXB 2 assay was performed as follows: either standards or samples were added to 50 mM phosphatebuffered saline solution (PBS) containing 0.01 M EDTA, 0.3% bovine -y-globulin, 0.005% Triton X-100, and 0.05% sodium azide (pH 6.8) to a total volume of 100 fi\. Fifty microliters of antisera (final dilution 1: 40,000) were added, followed by 50 yu. 1 of [ I25 I]TXB 2 containing 10,000 cpm. After overnight incubation at 4° C, 16% polyethylene glycol in 50 mM PBS was added to the tubes. The precipitated bound tracer was separated from the unbound ligand by centrifugation at 3,000 rpm for 30 minutes, and by decanting the supernatant. The radioactivity was counted in a Micromedic Systems Apex automatic gamma counter. The cross reactivities of the 6-keto-PGF, a , PGE,, andTXB7 2 antisera have been previously described. Perfusion buffer in volume assayed did not affect the standard curve of these RIAs.
To assay for leukotrienes by RIA, the renal effluent was processed by a modification of the method of Powell. 21 The effluent was acidified to pH 6.2 with HC1 and applied to a 1-gram open-bed, preactivated C-18 ODS column (J.T. Baker Chemical Co., Philipsbury, N.J.). The column was washed with water, and the products were eluted with 10 ml of 100% methanol. An aliquot of the methanol was evaporated under nitrogen, and the products were resuspended in the LTC 4 -RIA buffer. The LTC 4 -antiserum cross reactivities at 50% displacement was 50% for LTD 4 and 8% for LTE 4 .
Results
Effect ofBK Stimulation on Rabbit Kidney Arachidonic Acid Metabolism
Intra-arterial administration of BK to the ex vivo perfused HNK resulted in the dose-dependent synthesis of PGE,, PGI 2 , and TXA 2 . Treatment of the hydronephrotic animal with LPS 1 hour before removal of the ureter-obstructed kidney resulted in enhanced BKstimulated prostanoid synthesis during the first several hours of perfusion (Table 1 ). These differences in peptide-stimulated prostaglandin synthesis were eliminated by prolonged ex vivo perfusion 2 (current data not shown). The effects of LPS pretreatment were specific to the HNK because perfused unobstructed control kidneys from rabbits that received LPS pretreatment exhibited a minimal prostanoid synthetic response to BK (Table 2) . Notably, the effluents from BKstimulated HNK and CLK (±LPS) were devoid of guinea pig ileum contractile activity (bidassay for peptidoleukotrienes) and of detectable LTC 4 immunoreactivity.
Effect of fMLP Stimulation on Rabbit Kidney Arachidonic Acid Metabolism
Repeated intra-arterial administration of fMLP (100 ng) to the ex vivo perfused HNK stimulated PGE 2 , PGI 2 , and TXA 2 synthesis; this prostanoid synthetic response increased in magnitude with time of ex vivo perfusion (Figures lAand IB). Treatment of the rabbits with LPS 1 hour before removal and perfusion of the kidney eliminated the time dependent increase in metabolite synthesis and resulted in maximal eicosanoid production with the initial fMLP challenge ( Figures 1A and IB ). Tachyphylaxis occurred with frequent (20-minute intervals) fMLP stimulation of the HNK; therefore, fMLP stimulations were performed at hourly intervals. Stimulation of the rabbit HNK with fMLP resulted in the synthesis of peptidoleukotrienes, which were initially observed by bioassay (guinea pig ileum contraction) and subsequently quantitated by RIA for LTC 4 . Whereas fMLP-stimulated prostanoid synthesis was maintained or increased with perfusion time, leukotriene synthesis declined at prolonged perfusion times ( Figure IB) . The CLK pretreated with LPS and stimulated with fMLP (1,000 ng) produced far smaller quantities of prostaglandins and leukotrienes than the fMLP-stimulated HNK ( Table 2) .
Stimulation of the HNK with fMLP (30-1,000 ng) caused a dose-dependent synthesis of PGE;, PGI 2 (Figures 2A) , TXA 2 , and LTQ ( Figure 2B ). Treatment Hydronephrotic rabbits were either treated or not treated with LPS 1 hour before sacrifice. The HNKs were then removed and perfused ex vivo for 3-4 hours before stimulation with a maximal dose of either fMLP or BK. Maximal eicosanoid synthetic responses were obtained with 300 ng BK or fMLP in LPS-pretreated animals and with 1 ^ig BK or fMLP in nonpretreated animals. Values shown were determined by specific RIA and are expressed as nanograms of product measured in a 5-minute (50 ml) collection of effluent ± SEM. Ellipses indicate that the levels were not detectable. The synthesis of each metabolite elicited by BK was compared with the synthesis elicited by fMLP using a Student's I test for unpaired data. The 2 pretreatment groups (±LPS) were analyzed separately, */?<0.05. The CLK (n = 3) and the HNK (n = 7) were perfused for 1 and 5 hours before the 5-minute collection (50 ml) of effluent before (basal) and immediately after a bolus intra-arterial BK or fMLP administration. Values shown were determined by specific RIAs as described in "Materials and Methods" and are expressed as nanograms of product released (minus basal levels) during a 5-minute (10 ml/min) collection period + SEM. Statistical comparisons of eicosanoid levels between HNK and CLK were performed for each agonist at each time point using a Student's t test for unpaired data, *p<0.05. Ellipses indicate that the levels were undetectable.
of the hydronephrotic animal with LPS 1 hour before kidney perfusion resulted in a leftward shift of the fMLP dose-response curves for eicosanoid synthesis (Figures 2A and 2B ) and in an increase in the maximal response to fMLP ( Table 1) .
Validation of Leukotriene Production in the fMLP-Stimulated HNK
Since the LTC 4 antiserum cross reacts with LTD 4 and LTE 4 , the RIA did not distinguish the species of leukotrienes released from the HNK. RP-HPLC separation of the products released from the fMLPstimulated HNK revealed the presence of LTB 4 , LTC 4 , LTD 4 , and LTE 4 in the renal venous effluent as detected by comigration with authentic leukotriene standards. RIAs for LTC 4 from the HPLC fractions confirmed its presence in the appropriate fractions. To obtain sufficiently pure material for ultraviolet spectral analysis, effluent was pooled from 4 LPS-treated HNKs (stimulated 3 times with 100 ng of fMLP). The results of the RP-HPLC and LTC 4 RIA are presented in Figure 3 . The fractions comigrating with LTB 4 and LTD 4 standards contained sufficient material for ultraviolet spectral analysis. The HPLC fraction that comigrated with LTD 4 had a peak absorbance at 280 nm with shoulders at 270 and 290 nm. The LTB 4 fraction had a peak absorbance at 270 nm with shoulders at 260 and 280 nm. These results are consistent with published absorbance spectral profiles for LTD 4 and LTB 4 . The amounts of LTC 4 and LTE 4 in the appropriate fractions were inadequate for ultraviolet spectral analysis. Further confirmation of the presence of peptidoleukotrienes in the HPLC fractions was obtained by the guinea pig ileum bioassay. An aliquot of the fraction comigrating with LTD 4 contracted the guinea pig ileum to a similar extent as 30 ng LTD 4 , and this contraction was inhibited by FPL-55712. The fractions comigrat-ing with LTC 4 and LTE 4 contained insufficient material to contract the guinea pig ileum, and LTB 4 did not possess this bioactivity. Effluent subjected to RP-HPLC from unobstructed kidneys and unstimulated or BKstimulated HNKs served as negative controls. Basal effluent (600 ml) from control kidneys and HNKs (± LPS) processed as described in "Materials and Methods" and subjected to RP-HPLC lacked peak absorbances at 280 nm with retention times similar to leukotriene standards. All of the resulting HPLC fractions lacked leukotrienes as determined by LTC 4 RIA. Similarly, the pooled effluent from BK-stimulated kidneys (600 ml) (CLK or normal and HNK ± LPS) contains neither guinea pig ileum contractile activity nor leukotrienes as detected by HPLC and RIA. The effluent from CLK taken from animals pretreated with LPS showed an attenuated synthesis of LTB 4 and LTC 4 after fMLP stimulation. Stimulation of a CLK with 1,000 ng of fMLP produced less than 1 /10 of the LTB 4 and 1/50 of the LTC 4 produced by an HNK stimulated with 100 ng of fMLP.
Effects of Endogenousty Produced Leukotrienes and Thromboxane on Renal Vascular Resistance in the Ex Vivo Perfused HNK
Administration of BK and fMLP to the HNK from animals treated with LPS caused the synthesis of several vasoactive arachidonic acid metabolites. We used the leukotriene receptor antagonist FPL-55712 and the thromboxane synthase inhibitor OKY-1581 to determine the effects of endogenously produced peptidoleukotrienes and thromboxane on renal perfusion pressure. Under constant flow conditions, as performed in these experiments, increased perfusion pressure indicates increased vascular resistance. Administration of fMLP to the LPS-treated HNK resulted in an increase in perfusion pressure, coincident with the synthesis of thromboxane and peptidoleukotrienes (Figure 4 ). Intrarenal infusion of the thromboxane synthase inhibitor OKY-1581 inhibited both the fMLPstimulated TXA 2 synthesis and renal vasoconstriction. Administration of 100 ng of fMLP stimulated TXA 2 production from basal levels of 5.9 ± 1.2 to 121 ±22 ng (n = 8), which were significantly inhibited by OKY-1581 to levels of 5.8 ±2.7 ng (n = 5). Perfusion pressure increased with fMLP stimulation by 45 ± 10 mm Hg (n= 12) or by 3± 1 mm Hg (n = 5) in the presence of OKY-1581. Interestingly, the LT-receptor antagonist FPL-55712 partially inhibited the fMLPstimulated TXA 2 synthesis (59 ± 20 ng, n = 1, p<0.05) and the renal vasoconstriction [an increase of perfusion pressure of only 14 ± 4 mm Hg (n = 8)]. Stimulation of the LPS-treated CLK with 1,000 ng fMLP did not cause a change in perfusion pressure. BK administration to the LPS-treated HNK resulted in the production of TXAj, PGF^, and PGI 2 in association with a transient renal vasoconstriction. OKY-1581 inhibited BKstimulated TXA 2 synthesis specifically. Therefore, the renal vasodilation observed after BK administration in the presence of OKY-1581 presumably resulted from the effect of PGE 2 and PGI 2 . As would be expected, FPL-55712 had no effect on BK-stimulated vasoconstriction. A representative tracing, along with the corresponding TXA 2 values, from these experiments is shown in Figure 4 . In this experiment BK stimulation of the HNK in the absence or presence of inhibitors (i.e., OKY-1581 or FPL-55712) produced 1,683 ±91 ngPGEj/S-mincollection. Likewise, fMLP-stimulated PGE 2 production was unaffected by the inhibitors and ranged from 68 to 89 ng/5-min collection. BK-and fMLP-stimulated PGI, synthesis was also unaltered by OKY-1581 and FPL-55712.
Effect of Exogenously Administered LTC 4 on Thromboxane Production and Renal Vascular Resistance in the Ex Vivo Perfused Rabbit Kidney
Intra-arterial administration of LTC 4 (1-10 ^ig) to the LPS-treated HNK caused a dose-dependent release of TXA 2 (6.8-25.4 ng/50 ml). Only at the highest dose of LTC 4 (10 /xg) was the renal arterial perfusion pressure increased above baseline (from 58 ±9 to 74 ± 10 mm Hg; n = 4,/?<0.05). This dose of LTC 4 also stimulated the release of TXA 2 (from 5.1 ±1.3 to 41.7±11.9 ng/50 ml; n = 4, p<0.05). In the LPStreated control CLK, LTC< did not stimulate the production of TXA 2 or cause a change in perfusion pressure. Administration of LTD 4 (10 fig) to the LPS-treated HNK or CLK did not stimulate TXA 2 production or change renal vascular resistance. Perfusion of the HNK with OKY-1581 or FPL-55712 inhibited the LTC 4 -mediated TXA 2 production and vasoconstriction ( Figure 5 ). Full recovery of the TXA 2 synthetic capacity and vasomotor activity of the HNK after administration of each inhibitor was monitored by the ability of fMLP to stimulate TXA 2 synthesis and increase perfusion pressure.
Discussion
This study demonstrates several novel aspects of arachidonate metabolism in renal inflammation using the rabbit hydronephrotic kidney model. Leukotrienes were produced by the ex vivo perfused HNK in response to fMLP stimulation. This effect was greatly exaggerated by treating the hydronephrotic animal with LPS 1 hour before kidney perfusion. Peptidoleukotriene production in the HNK was initially detected in the renal effluent by bioassay. The presence of LTC 4 , LTD 4 , and LTE 4 in the renal effluent was further confirmed by RP-HPLC and RIA. Both endogenous and exogenous LTC 4 were shown to stimulate TXA 2 synthesis in the HNK but not in the CLK. This LTQ-stimulated TXA 2 synthesis resulted in renal vasoconstriction.
Although the cellular source of agonist-stimulated leukotriene synthesis in the HNK is unknown, there are several compelling lines of evidence suggesting an inflammatory cell origin. The fMLP stimulation of leukotriene and prostaglandin production in the HNK is most likely due to the infiltration of inflammatory cells since fMLP receptors have been demonstrated only on inflammatory cells such as polymorphonuclear leukocytes 2223 and macrophages. 24 Inflammatory cells in vitro stimulated with fMLP also produce leukotrienes. 252 * The unresponsiveness of the CLK to fMLP stimulation (little or no leukotriene production) is consistent with the low numbers of resident tissue macrophages. The hypothesis that the HNK-produced leukotrienes originate from inflammatory cells is further supported by the unmasked leukotriene production in the fMLP-stimulated HNK from rabbits treated with LPS, an inflammatory cell agonist. This novel production of leukotrienes is likely to result from LPS activation of the inflammatory cells recruited in vivo by the primary stimulus of tissue damage (in this case caused by ureter obstruction). Alternatively, LPS might stimulate inflammatory cell adherence to endothelium 27 and migration into damaged organs. 28 This seems less likely since fMLP stimulation of the CLK from rabbits treated with LPS causes minimal leukotriene production. The data obtained in this study suggest that fMLP and BK stimulate different cell types in the HNK and that the involved cells are present in the injured (HNK) but not the control (CLK) kidney. Three observations support this hypothesis. First, we are unaware of any evidence that demonstrates that BK directly stimulates macrophages or monocytes; we have treated cultured resident peritoneal macrophages with up to 1 jaM BK and not observed the release of eicosanoids (data not shown). Others have reported similar results . w Secondly, BK (up to a 3,000-ng bolus) did not release detectable levels of leukotrienes from the HNK (± endotoxin in vivo pretreatment) even when assayed with a very sensitive immunoassay (10-30 peg LTC/D readily analyzed) following extraction of large volumes of renal effluent. Finally, the dose-response comparison of the agonist effect on the HNK demonstrates differential quantitative metabolite production, such that BK stimulation induces the release of 5-10 times more PGE 2 and 6-keto-PGF lct , comparable TXB 2 (maximal response is approximately 200 ng/50 ml with both agonists), and much less leukotriene (BKundetectable versus fMLP approximately 50 ng/50 ml) than fMLP. Leukotriene-stimulated TXA 2 production has previously been demonstrated in guinea pig lungs 30 and cultured bovine aortic endothelial cells. 3 ' This leukotriene-stimulated TXA 2 production is abolished by pretreatment with the leukotriene receptor antagonist FPL-55712. We demonstrated that the ex vivo perfused HNK (but not the CLK) from rabbits treated with LPS responds to fMLP stimulation with the synthesis of leukotrienes that, in turn, caused production of thromboxane. These experiments represent a unique example of an inflammatory state in which leukotrienes acquire the ability to stimulate TXA 2 synthesis. Likewise, this is a novel example of endogenously produced leukotrienes stimulating the production of TXA 2 . These results indicate that inflammation confers on a previously unresponsive tissue the capacity for leukotriene synthesis and that endogenous leukotrienes in the HNK cause a response not detected in normal tissue.
The effect of leukotrienes (through TXA 2 synthesis) on renal vascular resistance was also altered by the in vivo inflammatory state. Only in the LPS-treated hydronephrotic animal did the ex vivo perfusion pressure of the HNK increase with administration of fMLP and LTQ. This newly acquired response to leukotrienes, mediated in part by the level and condition of inflammatory cells, may have an important impact on renal function. The renal vasoconstriction could reduce renal blood flow, cause tissue ischemia, and exacerbate tissue damage. The enhanced leukotriene production in the rabbit HNK also has the capacity to alter physiologic effects not examined in these studies. Potentially, altered leukotriene production in the HNK could enhance vascular leakage and stimulate inflammatory cell chemotaxis. These effects could, in turn, cause further inflammatory cell activation and further tissue damage.
The exaggerated PGE^ and PGI 2 production induced by agonists in the HNK may conceivably provide a negative feedback modulation of the metabolic processes initiated by the invading inflammatory cells. PG^ suppresses: 1) the expression (as does PGI 2 ) of the Class II histocompatability molecule, la, on macrophages 32 ; 2) the macrophage production of interleukin-1," a factor that we earlier demonstrated to stimulate eicosanoid metabolism in fibroblasts, endothelial cells, and vascular smooth muscle cells 34 ; and 3) macrophage cytotoxicity. 9 Collectively, these observations suggest that regional production of PGE 2 at the site of injury may negatively modulate local macrophage metabolism and function. 1 In these studies, we demonstrate the production of leukotrienes in a renal model of inflammation, the HNK. The endogenously produced leukotrienes stimulated TXA 2 synthesis, resulting in renal vasoconstriction. The synthesis of leukotrienes and the ability of leukotrienes to stimulate thromboxane synthesis and subsequent renal vasoconstriction occurs only in the injured kidney, demonstrating both enhanced leukotriene production and enhanced leukotriene-mediated effects in hydronephrosis. Collectively, these data demonstrate the synthesis of leukotrienes in hydronephrosis and suggest their pathophysiologic importance in renal inflammation.
